Exploring the Inflammatory Phenotype and Direction of Future Trials in the Statin Domain of the remap cap Trial

This chapter explores the findings of the statin domain in the remap cap trial, specifically focusing on the inflammatory phenotype of patients. It raises questions about phenotyping diseases or individuals, discusses limitations of current labels, and emphasizes the need for a better understanding of underlying biology.